Stocks in Focus : MGM Resorts (NYSE:MGM), NPS Pharmaceuticals (NASDAQ:NPSP), LeMaitre Vascular (NASDAQ:LMAT), Range Resources (NYSE:RRC), BlackRock Maryland Municipal (NYSEMKT:BZM)

The Women’s Leadership Conference announces its 2014 program featuring two days of keynote speakers, breakout sessions, luncheons and networking opportunities. The conference, themed “Women Inspiring Women,” will be held Aug. 6 & 7 at the MGM Resorts International (NYSE:MGM) Grand Conference Center in Las Vegas. MGM Resorts International (NYSE:MGM)’s stock on 30 July traded at beginning with a price of $27.13and when day-trade ended the … Continue reading Stocks in Focus : MGM Resorts (NYSE:MGM), NPS Pharmaceuticals (NASDAQ:NPSP), LeMaitre Vascular (NASDAQ:LMAT), Range Resources (NYSE:RRC), BlackRock Maryland Municipal (NYSEMKT:BZM)

Morning Buzz – Yahoo! Inc. (NASDAQ:YHOO) , Reynolds American , Realogy (NYSE:RLGY) , NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) , ESB Financial Corporation (NASDAQ:ESBF)

Yahoo! Inc. (NASDAQ:YHOO) announced Monday it reached a definitive agreement to acquire six-year-old mobile analytics startup Flurry. Yahoo! Inc. (NASDAQ:YHOO) stock performance was -0.15% in last session and finished the day at $33.28. Traded volume was 18.43million shares in the last session and the average volume of the stock remained 19.69million shares. The beta of the stock remained 1.01. Yahoo! Inc. (NASDAQ:YHOO) insider ownership is … Continue reading Morning Buzz – Yahoo! Inc. (NASDAQ:YHOO) , Reynolds American , Realogy (NYSE:RLGY) , NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) , ESB Financial Corporation (NASDAQ:ESBF)

FB Nasdaq FB Facebook

Healthcare Active Stocks: AstraZeneca plc (ADR) (NYSE:AZN), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Gilead Sciences, Inc. (NASDAQ:GILD)

AstraZeneca Plc (ADR) (NYSE:AZN), in the headlines for spurning buyout offers from Pfizer Inc, aims to regain prominence in oncology with compelling trial results and a splashy exhibit booth at the world’s largest meeting of cancer doctors. AstraZeneca plc (ADR) (NYSE:AZN) stock performance was -0.83% in last session and finished the day at $72.76. Traded volume was 5.14million shares in the last session and the … Continue reading Healthcare Active Stocks: AstraZeneca plc (ADR) (NYSE:AZN), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Gilead Sciences, Inc. (NASDAQ:GILD)

FB Nasdaq FB Facebook

Healthcare Gainers: BioScrip Inc (NASDAQ:BIOS), NPS Pharmaceuticals (NASDAQ:NPSP), RadNet Inc. (NASDAQ:RDNT), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

BioScrip Inc (NASDAQ:BIOS), on May 8, 2014 announced 2014 first quarter financial results. First quarter revenue from continuing operations was $239.6 million and the net loss from continuing operations was $25.4 million, or $0.37 per basic and diluted share. Non-GAAP adjusted loss from continuing operations per basic and diluted share was $0.13.BioScrip Inc (NASDAQ:BIOS) stock performance was 17.08% in last session and finished the day … Continue reading Healthcare Gainers: BioScrip Inc (NASDAQ:BIOS), NPS Pharmaceuticals (NASDAQ:NPSP), RadNet Inc. (NASDAQ:RDNT), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

Biotech Top Gainers: OXiGENE Inc (NASDAQ:OXGN), Cell Therapeutics Inc (NASDAQ:CTIC), Arca Biopharma Inc (NASDAQ:ABIO), NPS Pharmaceuticals (NASDAQ:NPSP)

Biopharmaceutical giant Oxigene Inc (NASDAQ:OXGN) y reported its experimental drug Zybrestat, combined with Roche’s cancer drug Avastin, significantly slowed progression of recurrent ovarian cancer. OXiGENE Inc (NASDAQ:OXGN) stock performance was 77.27% in last session and finished the day at $4.29. Traded volume was 29,290,814 million shares in the last session and the average volume of the stock remained 569.72 million shares. The beta of the … Continue reading Biotech Top Gainers: OXiGENE Inc (NASDAQ:OXGN), Cell Therapeutics Inc (NASDAQ:CTIC), Arca Biopharma Inc (NASDAQ:ABIO), NPS Pharmaceuticals (NASDAQ:NPSP)

Biotech Losers: Aegerion Pharmaceuticals (NASDAQ:AEGR), Insys Therapeutics (NASDAQ:INSY), NPS Pharmaceuticals (NASDAQ:NPSP), XOMA Corp (NASDAQ:XOMA)

The Rosen Law Firm, P.A. reminds purchasers of Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) between March 15, 2012 and January 9, 2014, inclusive (the “Class Period”) of the important Mach 17, 2014 lead plaintiff deadline in the class action seeking remedies under the federal securities laws. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) stock performance was -5.40% in last session and finished the day at $53.74. Traded volume was 1,222,609 … Continue reading Biotech Losers: Aegerion Pharmaceuticals (NASDAQ:AEGR), Insys Therapeutics (NASDAQ:INSY), NPS Pharmaceuticals (NASDAQ:NPSP), XOMA Corp (NASDAQ:XOMA)